Sam Brusco, Associate Editor06.22.23
Philips has teamed up with Biotronik to expand the range of cardiovascular devices available for Philips SymphonySuite customers.
SymphonySuite is a solution to open and expand cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). It has a full range of specialized equipment and devices, personalized services, financing options, site planning, ongoing operational support, and device programs.
Combining Philips SymphonySuite and Biotronik’s cardiac rhythm management, cardiovascular intervention, and peripheral vascular intervention portfolio offers more options to individualize care and create treatment strategies for low-risk cardiac procedures in these settings.
“Philips is committed to expanding access to care through its innovative solutions and BIOTRONIK’s alliance adds additional devices, including a cardiac rhythm management portfolio, to SymphonySuite,” Chris DeCarolis, head of procedural solutions for image guided therapy at Philips, told the press. “We will continue to evolve to stay ahead of the needs of physicians and patients and provide cardiovascular equipment, devices and services in out-of-hospital settings while reducing cost pressures via innovative business models.”
Atul Suri, vice president of commercial excellence at Biotronik, added: “Through BIOTRONIK’s innovative cardiovascular technologies, we’re committed to partnering with outpatient sites of service. Aligning with Philips will allow us to bring greater value to our outpatient customers, particularly those with capital equipment needs for ASC and OBL facilities.”
SymphonySuite is a solution to open and expand cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). It has a full range of specialized equipment and devices, personalized services, financing options, site planning, ongoing operational support, and device programs.
Combining Philips SymphonySuite and Biotronik’s cardiac rhythm management, cardiovascular intervention, and peripheral vascular intervention portfolio offers more options to individualize care and create treatment strategies for low-risk cardiac procedures in these settings.
“Philips is committed to expanding access to care through its innovative solutions and BIOTRONIK’s alliance adds additional devices, including a cardiac rhythm management portfolio, to SymphonySuite,” Chris DeCarolis, head of procedural solutions for image guided therapy at Philips, told the press. “We will continue to evolve to stay ahead of the needs of physicians and patients and provide cardiovascular equipment, devices and services in out-of-hospital settings while reducing cost pressures via innovative business models.”
Atul Suri, vice president of commercial excellence at Biotronik, added: “Through BIOTRONIK’s innovative cardiovascular technologies, we’re committed to partnering with outpatient sites of service. Aligning with Philips will allow us to bring greater value to our outpatient customers, particularly those with capital equipment needs for ASC and OBL facilities.”